"
Team:LIKA-CESAR-Brasil/Hybridization
From 2014.igem.org
(Difference between revisions)
| Line 12: | Line 12: | ||
<link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.2.0/css/bootstrap.min.css"> | <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.2.0/css/bootstrap.min.css"> | ||
| - | + | <style type="text/css"> | |
body { | body { | ||
font-size:12px; | font-size:12px; | ||
| Line 245: | Line 245: | ||
</style> | </style> | ||
| - | |||
</head> | </head> | ||
| - | |||
<body> | <body> | ||
| - | |||
<div class="navbar navbar-inverse navbar-fixed-top" role="navigation"> | <div class="navbar navbar-inverse navbar-fixed-top" role="navigation"> | ||
<div class="container"> | <div class="container"> | ||
Revision as of 02:04, 18 October 2014
NOTEBOOK
Hybridization Process
To perform the hybridization process, 3μL target synthetic solution (miRNA) at different concentrations (1x10-6 the 1x10-12M) was dropped on the working electrode. The electrode remained under 300 rpm agitation at a temperature of annealing of 52 ° C for 10 minutes (the description of the manufacturing company sequence). Tests positive for breast cancer provided by the Baron of Lucena-PE Hospital biological samples were also performed. After completion of the hybridization tests with different targets, hybridization tests with non-complementary targets were made.
